TIFFANY MCCRAY: Open Payments
NPI 1417999657 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 36 payments from 9 companies in 2025. Trend: 2023 $958 · 2024 $1,368 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $389 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| Novartis Pharmaceuticals Corporation | 5 | $88 |
| Galderma Laboratories, L.P. | 2 | $38 |
| Incyte Corporation | 1 | $25 |
| UCB, Inc. | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| LEO Pharma Inc. | 1 | $14 |
| Organon LLC | 1 | $9 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, COSENTYX, OPZELURA, Bimzelx, NEMLUVIO, Zoryve.
Industry payments across ID — which companies pay providers there.
